187 related articles for article (PubMed ID: 29247440)
1. Analysis of breast cancer in young women in the Department of Defense (DOD) database.
Zimmer AS; Zhu K; Steeg PS; Wu A; Gatti-Mays ME; Soltani S; Perkins JG; Shao S; Brown D; Georg M; Hu H; Shriver CD; Lipkowitz S
Breast Cancer Res Treat; 2018 Apr; 168(2):501-511. PubMed ID: 29247440
[TBL] [Abstract][Full Text] [Related]
2. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
[TBL] [Abstract][Full Text] [Related]
3. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
Elledge RM; Clark GM; Chamness GC; Osborne CK
J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
[TBL] [Abstract][Full Text] [Related]
4. Widening disparity in survival between white and African-American patients with breast carcinoma treated in the U. S. Department of Defense Healthcare system.
Jatoi I; Becher H; Leake CR
Cancer; 2003 Sep; 98(5):894-9. PubMed ID: 12942554
[TBL] [Abstract][Full Text] [Related]
5. Breast carcinoma survival analysis for African American and white women in an equal-access health care system.
Wojcik BE; Spinks MK; Optenberg SA
Cancer; 1998 Apr; 82(7):1310-8. PubMed ID: 9529023
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Chen L; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
[TBL] [Abstract][Full Text] [Related]
7. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006.
Fedewa SA; Ward EM; Stewart AK; Edge SB
J Clin Oncol; 2010 Sep; 28(27):4135-41. PubMed ID: 20697082
[TBL] [Abstract][Full Text] [Related]
8. Racial disparities in omission of oncotype DX but no racial disparities in chemotherapy receipt following completed oncotype DX test results.
Press DJ; Ibraheem A; Dolan ME; Goss KH; Conzen S; Huo D
Breast Cancer Res Treat; 2018 Feb; 168(1):207-220. PubMed ID: 29181717
[TBL] [Abstract][Full Text] [Related]
9. Disparities in receipt of care for high-grade endometrial cancer: A National Cancer Data Base analysis.
Bregar AJ; Alejandro Rauh-Hain J; Spencer R; Clemmer JT; Schorge JO; Rice LW; Del Carmen MG
Gynecol Oncol; 2017 Apr; 145(1):114-121. PubMed ID: 28159409
[TBL] [Abstract][Full Text] [Related]
10. A tracking and feedback registry to reduce racial disparities in breast cancer care.
Bickell NA; Shastri K; Fei K; Oluwole S; Godfrey H; Hiotis K; Srinivasan A; Guth AA
J Natl Cancer Inst; 2008 Dec; 100(23):1717-23. PubMed ID: 19033569
[TBL] [Abstract][Full Text] [Related]
11. Does race predict survival for women with invasive breast cancer?
Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
[TBL] [Abstract][Full Text] [Related]
12. Persistent disparities in breast cancer surgical outcomes among hispanic and African American patients.
Mets EJ; Chouairi FK; Gabrick KS; Avraham T; Alperovich M
Eur J Surg Oncol; 2019 Apr; 45(4):584-590. PubMed ID: 30683449
[TBL] [Abstract][Full Text] [Related]
13. Racial disparities in treatment and survival of male breast cancer.
Crew KD; Neugut AI; Wang X; Jacobson JS; Grann VR; Raptis G; Hershman DL
J Clin Oncol; 2007 Mar; 25(9):1089-98. PubMed ID: 17369572
[TBL] [Abstract][Full Text] [Related]
14. Racial Differences in Time to Breast Cancer Surgery and Overall Survival in the US Military Health System.
Eaglehouse YL; Georg MW; Shriver CD; Zhu K
JAMA Surg; 2019 Mar; 154(3):e185113. PubMed ID: 30673075
[TBL] [Abstract][Full Text] [Related]
15. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina.
Jackson LC; Camacho F; Levine EA; Anderson RT; Stewart JH
Am J Surg; 2008 Feb; 195(2):164-9. PubMed ID: 18096124
[TBL] [Abstract][Full Text] [Related]
16. Differences in breast cancer stage, treatment, and survival by race and ethnicity.
Li CI; Malone KE; Daling JR
Arch Intern Med; 2003 Jan; 163(1):49-56. PubMed ID: 12523916
[TBL] [Abstract][Full Text] [Related]
17. Effects of screening mammography on the comparative survival rates of African American, white, and Hispanic beneficiaries of a comprehensive health care system.
Wojcik BE; Spinks MK; Stein CR
Breast J; 2003; 9(3):175-83. PubMed ID: 12752625
[TBL] [Abstract][Full Text] [Related]
18. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
Hawley ST; Griggs JJ; Hamilton AS; Graff JJ; Janz NK; Morrow M; Jagsi R; Salem B; Katz SJ
J Natl Cancer Inst; 2009 Oct; 101(19):1337-47. PubMed ID: 19720966
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.
Griggs JJ; Hawley ST; Graff JJ; Hamilton AS; Jagsi R; Janz NK; Mujahid MS; Friese CR; Salem B; Abrahamse PH; Katz SJ
J Clin Oncol; 2012 Sep; 30(25):3058-64. PubMed ID: 22869890
[TBL] [Abstract][Full Text] [Related]
20. Delays in Diagnosis and Treatment of Breast Cancer: A Safety-Net Population Profile.
Jaiswal K; Hull M; Furniss AL; Doyle R; Gayou N; Bayliss E
J Natl Compr Canc Netw; 2018 Dec; 16(12):1451-1457. PubMed ID: 30545992
[No Abstract] [Full Text] [Related]
[Next] [New Search]
